AA Locums operates under UK Wholesale Dealer Authorisation (WDA(H)) and full Good Distribution Practice (GDP) compliance, regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). Every aspect of our operation — from supplier qualification to final delivery — is designed around documented, auditable standards.
Three frameworks govern everything we do.
The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK government body responsible for the safety, quality, and efficacy of medicines. AA Locums is regulated by the MHRA and operates under continuous compliance with its inspection standards.
A WDA(H) is the legal authorisation required to procure, hold, supply, or export human medicines in the UK. Our authorisation is held under the responsibility of our designated Responsible Person and covers the activities listed on our licence.
GDP is the UK and EU standard governing the storage, transport, and distribution of medicinal products. Our operating procedures, training programmes, and quality management system are designed to meet GDP requirements at every stage of the supply chain.
Our MHRA licence details can be verified on the public MHRA register. Verify Our MHRA Licence
Every UK pharmaceutical wholesaler must operate under the oversight of a designated Responsible Person. Ours leads from the front.
Responsible Person · GPhC-Registered Pharmacist Prescriber
Ansam Aljeraisi is the designated Responsible Person (RP) for AA Locums Pharma. As a GPhC-registered pharmacist prescriber, she holds personal accountability under MHRA regulations for ensuring that all wholesale activity at AA Locums meets Good Distribution Practice standards.
The RP's responsibilities include verifying every supplier and customer, approving release of medicinal products, overseeing our quality management system, managing deviations and recalls, and maintaining inspection readiness. At AA Locums, the RP is not an external consultant or a name on a licence — she is the company's operational and regulatory lead.
Our QMS is the operational backbone of our GDP compliance. It documents, controls, and continuously improves every process that touches a medicinal product.
Every supplier verified against MHRA licence status before any procurement activity.
Authorised purchaser status confirmed before any supply, in line with WDA(H) requirements.
Temperature-monitored zones with documented mapping and continuous data-logging.
Full forward and backward traceability maintained for every batch handled, supporting recall readiness.
Standard Operating Procedures (SOPs) version-controlled and reviewed on a defined cycle.
Documented response protocols for any quality event, with corrective and preventive action workflows.
Scheduled internal audits and continuous inspection-ready posture for MHRA visits.
Many medicinal products lose efficacy or become unsafe outside defined temperature ranges. Our cold chain procedures are designed to protect product integrity at every transition point.
Storage areas are temperature-mapped and continuously monitored, with validated calibration of monitoring equipment. Receipt and dispatch of temperature-sensitive products follow documented procedures, and any excursion outside specification is logged, investigated, and escalated through our deviation process. Where third-party logistics are used for transport, partners are qualified against the same GDP standards we apply internally.
Regulatory inspections are not events we prepare for in advance — they are the standard we operate to every day. All quality records, batch documentation, supplier qualifications, training logs, and temperature data are maintained in accordance with MHRA requirements and retained for the regulated period.
Customers and partners who require evidence of our compliance posture may request documentation directly through our Responsible Person.
If you supply, procure, or audit pharmaceutical distribution, talk to us.
